Molecular Modeling Studies of Natural Inhibitors of Androgen Signaling in Prostate Cancer
Samuel Olawale Olubode, Owolabi M. Bankole, Precious Ayorinde Akinnusi, Olayinka S. Adanlawo, Kehinde I. Ojubola, Daniel O. Nwankwo, Onome E Edjebah, Ayomide Oluwadarasimi Adebesin, Abigail O. Ayodele
Abstract
Prostate cancer is the second most common disease in men and the sixth leading cause of death from cancer globally, with 20 million men expected to be affected by 2024 thus considered as chronic illness which requires immediate attention. As an androgen-dependent illness that relies on the androgen receptor for development and progression, inhibition of the androgen receptor can lead to a therapeutic solution, hence serving as a vital therapeutic target. This study focused on the computational analysis of the inhibitory potentials of Vitis vinifera, a reported plant with anti-cancer properties, against androgen receptor employing molecular docking, ADMET studies, Binding energy study, pharmacophore modeling, and molecular dynamics simulation approaches. After the investigation, it was determined that 5 compounds: cis-piceid, cis-astrigin, gallocatechin, phlorizin, and trans-polydatin, might be possible androgen receptor inhibitors since they had higher docking scores and ADMET qualities than compared standards, with cis-piceid being the best-predicted inhibitor.